| 注册
首页|期刊导航|检验医学与临床|免疫调节机制在免疫性血小板减少症中的研究进展

免疫调节机制在免疫性血小板减少症中的研究进展

徐小凡 李一鸣 徐小虎 代义龙 金呈强

检验医学与临床2024,Vol.21Issue(9):1332-1335,1340,5.
检验医学与临床2024,Vol.21Issue(9):1332-1335,1340,5.DOI:10.3969/j.issn.1672-9455.2024.09.031

免疫调节机制在免疫性血小板减少症中的研究进展

Research progress of immunomodulatory mechanisms in immune thrombocytopenia

徐小凡 1李一鸣 1徐小虎 1代义龙 1金呈强2

作者信息

  • 1. 济宁医学院临床学院,山东济宁 272000
  • 2. 济宁医学院附属医院检验科,山东济宁 272007
  • 折叠

摘要

Abstract

Immune thrombocytopenia(ITP)is a rare hematological disease,belonging to acquired autoim-mune disease.Immune disorders are the main cause,and its pathogenesis is getting more and more attention.Current studies have shown that the indicators including the production of autoantiplatelet antibodies,imbal-ance of Th1/Th2 and Th17/Tregs,high proliferation and low apoptosis of cytotoxic T lymphocytes,reduced number and dysfunction of Bregs cells,apoptosis,heredity and autophagy play a key role in the pathogenesis of ITP.This paper reviews various complex mechanisms involved in the pathogenesis of ITP that have been dis-covered in recent years from the above six aspects,with the aim of providing a more comprehensive understanding of the factors affecting the development of ITP and providing new ideas and targets for the treatment of ITP.

关键词

免疫性血小板减少症/自身抗体/细胞自噬/血小板/免疫

Key words

immune thrombocytopenia/autoantibodies/autophagy/platelet/immunity

分类

医药卫生

引用本文复制引用

徐小凡,李一鸣,徐小虎,代义龙,金呈强..免疫调节机制在免疫性血小板减少症中的研究进展[J].检验医学与临床,2024,21(9):1332-1335,1340,5.

基金项目

山东省自然科学基金资助项目(ZR2010HL038、ZR20219BH050) (ZR2010HL038、ZR20219BH050)

山东省医药卫生科技发展计划项目(2017WS223) (2017WS223)

山东省高等学校科技计划项目(J15LL11) (J15LL11)

山东省中医药科技发展计划项目(2015-244) (2015-244)

济宁医学院教师科研扶持基金(JYFC2018FKJ096). (JYFC2018FKJ096)

检验医学与临床

OACSTPCD

1672-9455

访问量5
|
下载量0
段落导航相关论文